Medical Subject Headings (MeSH): Direct-to-Consumer Advertising

Direct-to-consumer (DTC) advertising in healthcare refers to the marketing of prescription drugs, medical devices, and other healthcare products directly to consumers through various channels, such as television, radio, print, and online media.

DTC advertising is regulated by the Food and Drug Administration (FDA) in the United States, which has established guidelines for the content and format of DTC advertisements. These guidelines require that DTC advertisements provide accurate and balanced information about the benefits and risks of the product being advertised, and that they include information about any potential side effects or interactions with other drugs or products.

DTC advertising in healthcare has been a controversial topic, as some people argue that it may lead to overuse or inappropriate use of healthcare products, and may contribute to rising healthcare costs. Others argue that DTC advertising helps to educate consumers about their healthcare options and may encourage them to seek medical attention for conditions that they may not have otherwise recognized or addressed.

Overall, direct-to-consumer advertising in healthcare refers to the marketing of prescription drugs, medical devices, and other healthcare products directly to consumers through various channels, and is regulated by the FDA in the United States.